Literature DB >> 9512178

Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

E Perez-Trallero1, M Urbieta, M Montes, I Ayestaran, J M Marimon.   

Abstract

The aim of this study was to determine the evolution of resistance to macrolides and other antibiotics in strains of Streptococcus pyogenes isolated in the province of Gipuzkoa, Spain. During the period 1984-1996, all 2561 strains of Streptococcus pyogenes studied showed full susceptibility to penicillin. Until 1990, only 1.2% of Streptococcus pyogenes isolates were resistant to erythromycin. Since then, resistance to erythromycin increased every year until 1995, when 34.8% (87/250) of Streptococcus pyogenes strains were found to be resistant. In 1996 the rate of resistance to erythromycin was 17.8% (75/422). During the study period, 96.1% (246/256) of the Streptococcus pyogenes isolates resistant to erythromycin were susceptible to clindamycin. Of the remaining erythromycin-resistant Streptococcus pyogenes strains, resistance to clindamycin was constitutive in seven strains and inducible in three. When investigated by the polymerase chain reaction (PCR), all Streptococcus pyogenes strains resistant to erythromycin and susceptible to clindamycin showed the 1.4 kb fragment of the mefA gene, recently described as the novel macrolide-efflux-resistance determinant. The most frequent T-agglutination patterns among Streptococcus pyogenes resistant to erythromycin were T4 and T8,25. The emergence and rapid spread of erythromycin-resistant Streptococcus pyogenes in Gipuzkoa and its relationship to the presence of the mefA gene are described.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512178     DOI: 10.1007/bf01584359

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

Review 2.  Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

3.  Erythromycin-resistant Streptococcus pyogenes.

Authors:  G Phillips; D Parratt; G V Orange; I Harper; H McEwan; N Young
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

4.  Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

Authors:  E Sanders; M T Foster; D Scott
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

5.  Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Authors:  J Clancy; J Petitpas; F Dib-Hajj; W Yuan; M Cronan; A V Kamath; J Bergeron; J A Retsema
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

6.  Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.

Authors:  G Cornaglia; M Ligozzi; A Mazzariol; M Valentini; G Orefici; R Fontana
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

7.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin.

Authors:  R J Scott; J Naidoo; N F Lightfoot; R C George
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

9.  Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.

Authors:  P R Hsueh; H M Chen; A H Huang; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

10.  Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.

Authors:  M Borzani; F Varotto; L Garlaschi; F Conio; M Dell'Olio; P Careddu
Journal:  J Chemother       Date:  1989-02       Impact factor: 1.714

View more
  21 in total

1.  Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.

Authors:  E L Palavecino; I Riedel; X Berrios; S Bajaksouzian; D Johnson; E Kaplan; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors:  J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.

Authors:  E Perez-Trallero; C Garcia; B Orden; J M Marimon; M Montes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-08       Impact factor: 3.267

Review 5.  Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Authors:  Corné H W Klaassen; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.

Authors:  Karel Urbánek; Milan Kolár; Luboslava Cekanová
Journal:  Pharm World Sci       Date:  2005-04

7.  Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.

Authors:  J J Yan; H M Wu; A H Huang; H M Fu; C T Lee; J J Wu
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 8.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

9.  Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.

Authors:  Meredith E Hasenbein; John E Warner; Kathleen G Lambert; Sarah E Cole; Andrew B Onderdonk; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 10.  Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.

Authors:  E Perez-Trallero; J M Marimón; M Montes; B Orden; M de Pablos
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.